Olalekan Ajayi, COO of Highlands Oncology Group, shared on LinkedIn:
“2025 was a heavy year in oncology.
New therapies. New rules. New pressures. Many of us felt the shift not in headlines, but in clinic workflows, reimbursement conversations, and patient access challenges. Here’s my take on the monumental things that shaped 2025.
As we move into 2026, I’d love to hear:
What stood out to you as the most impactful change in 2025? And what do you think will most shape oncology in the year ahead?”
More posts featuring Olalekan Ajayi on OncoDaily.